Santa Cruz Biotechnology features a diverse variety of Neuregulin-1 α monoclonal antibodies for various research applications. Neuregulin-1 α Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Neuregulin-1 α is a critical signaling molecule involved in the development and maintenance of the nervous system, as well as in cardiac function. It plays a significant role in the regulation of neuronal survival, differentiation, and synaptic plasticity. Neuregulin-1 α influences multiple cellular processes, including cell proliferation, migration, and differentiation in both neural and cardiac tissues. Research has shown that Neuregulin-1 α signaling pathways are essential for proper neuromuscular junction formation and maintenance. Additionally, Neuregulin-1 α has been implicated in various pathological conditions, including schizophrenia and heart disease, making it an important target for research. Understanding Neuregulin-1 α mechanisms can lead to potential therapeutic strategies for treating neurological and cardiovascular disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge of Neuregulin-1 α's role in health and disease.